Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures


Last Updated: March 1, 2018; Last Reviewed: March 1, 2018

Mycobacterium tuberculosis Infection and Disease
Member Financial Disclosure
Company Relationship
Brust, James* Albert Einstein College of Medicine None N/A
Dooley, Kelly Johns Hopkins University Viiv Health Care Research Support
Maartens, Gary University of Cape Town, South Africa Janssen Consultant
Meintjes, Graeme University of Cape Town, South Africa Gilead Research Support
Shah, Sarita Centers for Disease Control and Prevention None N/A
Sterling, Timothy Vanderbilt University Sanofi Consultant
*Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from March 1, 2017, through March 1, 2018.

Download Guidelines